Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Biology and Environment (2)
- Advanced Manufacturing (2)
- Clean Energy (11)
- Computer Science (1)
- Fusion and Fission (1)
- Fusion Energy (10)
- Materials (19)
- Materials for Computing (1)
- National Security (3)
- Neutron Science (34)
- Nuclear Science and Technology (10)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
- Supercomputing (11)
News Topics
- (-) Molten Salt (1)
- (-) Neutron Science (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (2)
- Biology (3)
- Biomedical (4)
- Chemical Sciences (2)
- Climate Change (3)
- Composites (1)
- Computer Science (4)
- Coronavirus (4)
- Energy Storage (1)
- Environment (4)
- High-Performance Computing (1)
- Isotopes (1)
- Machine Learning (1)
- Materials (2)
- Materials Science (1)
- Nanotechnology (3)
- Physics (1)
- Summit (2)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.